김병식 교수
전문진료분야
위암, 비만대사질환, 위장관 점막하종양, 위궤양, 역류성 식도염, 식도열공탈장, 위암 수술 후 추적관찰, 담낭질환, 개복/복강경/로봇 수술
전화 예약
1577-1801
기본정보
학력
1991.03 ~ 1995.09서울대학교 의과대학원 의학 박사 1989.03 ~ 1991.02서울대학교 의과대학원 의학 석사 1976.03 ~ 1982.02서울대학교 의과대학 의학 학사 |
경력
2023.02 ~ 2025.08차의과학대학교 강남차병원 위장관외과 임상교수 2021.09 ~ 2023.01의정부 을지대학교병원 위장관외과 교수 2022.01 ~ 2022.12의정부을지대학교병원 병원장 2021.03 ~ 2021.12의정부을지대학교병원 의료원장 2016.09 ~ 2020.08서울아산병원 외과 과장 2002.10 ~ 2021.02서울아산병원 외과 교수 2009.03 ~ 2016.12서울아산병원 부원장 2006.03 ~ 2009.02서울아산병원 외래부장/입원부장 1995.07 ~ 1996.06일본 kanazawa 대학교 의과대학 제 2외과학 교실 초청교수 1993.10 ~ 2002.09서울아산병원 외과 부교수 1991.09 ~ 1993.09서울아산병원 외과 조교수 1990.03 ~ 1991.08서울아산병원 외과 전임의 1986.03 ~ 1990.02서울대학교병원 전공의 1985.05 ~ 1986.02서울대학교병원 인턴 |
학회활동
대한위암학회 정회원 대한외과학회 정회원 대한암학회 정회원 대한내시경복강경외과학회 정회원 대한비만대사외과학회 정회원 대한종양외과학회 정회원 대한위장관기질종양연구회 정회원 대한외과대사영양학회 정회원 일본위암학회 정회원 국제위암학회 정회원 |
논문
1) Chang Seok Ko, Jin Ho Jheong, Seong-A Jeong, Byung Sik Kim, Jeong Hwan Yook, Beom Su Kim, In-Seob Lee, Chung Sik Gong, Na Young Kim, Moon-Won Yoo. Safety evaluation of curative gastrectomy for gastric cancer patients who underwent liver transplantation: a comparative study with conventional gastrectomy for gastric cancer patients. World J Surg Oncol. 2023 May 11;21(1):145.
2) Chang Seok Ko, Jin Ho Jheong, Seong-A Jeong, Byung Sik Kim, Jeong Hwan Yook, Moon-Won Yoo, Beom Su Kim, In-Seob Lee, Sehee Kim, Chung Sik Gong. Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer. Ann Surg Oncol. 2022 Aug;29(8):5076-5082.
3) Chang Seok Ko, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim 4A comparative study of laparoscopic near-total and total gastrectomy for patient nutritional status and quality of life using a propensity score matching analysis. 2022 Aug;36(8):5610-5617.
4) So S, Noh JH, Ahn JY, Lee IS, Lee JB, Jung HY, Yook JH, Kim BS. Scoring Model Based on Nodal Metastasis Prediction Suggesting an Alternative Treatment to Total Gastrectomy in Proximal Early Gastric Cancer. J Gastric Cancer. 2022 Mar;22(1):24-34.
5) Ko CS, Jheong JH, Jeong SA, Gong CS, Lee IS, Kim BS, Kim BS, Park HS, Min SH, Yoo MW. Early Clinical Outcomes of the Morbidly Obese Patients Who Underwent Laparoscopic Sleeve Gastrectomy by Gastric Cancer Surgeons: the Analysis of Fifty Consecutive Cases. J Metab Bariatr Surg. 2021 Dec;10(2):66-73
6) Ko CS, Choi NR, Kim BS, Yook JH, Kim MJ, Kim BS. Totally laparoscopic total gastrectomy using the modified overlap method and conventional open total gastrectomy: A comparative study. World J Gastroenterol. 2021 May 14;27(18):2193-2204.
7) Lee IS, Sahu D, Hur H, Yook JH, Kim BS, Goel A. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer. Gastric Cancer. 2021 May;24(3):655-665.
8) Lee IS, Lee H, Hur H, Kanda M, Yook JH, Kim BS, Woo Y, Kodera Y, Kim K, Goel A. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer. Clin Cancer Res. 2021 Apr 15;27(8):2292-2300.
9) Amy Kim, Chang Seok Ko, Hee Sung Kim, Byung Sik Kim. Intracorporeal bi-directional pouch jejunojejunostomy following Roux-en-Y anastomosis: A simple reconstruction technique using an endoscopic linear stapler. Videosurgery and other miniinvasive techniques. 2021 Apr 30;16(4):704–709.
10) Choi NY, Kim BS, Oh ST, Yook JH, Kim BS. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach. Am Surg. 2021 Apr;87(4):631-637.
11) Shin E, Bae S, Jung J, Song WJ, Kwon HS, Kim HS, Kim SH, Kim TB, Cho YS, Lee JH. Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine. Allergy. 2021 Jun 15.
12) Kim KW, Lee K, Lee JB, Park T, Khang S, Jeong H, Ko CS, Yook JH, Kim BS, Lee IS. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study. BMC Cancer. 2021 Feb 12;21(1):157.
13) Chang Seok Ko, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim. Overlap method versus functional method for esophagojejunal reconstruction using totally laparoscopic total gastrectomy. Surg Endosc. 2021 Jan;35(1):130-138.
14) Shin EJ, Gong CS, Kim BS, Kim SO, Ko CS, Kim HS. Early Surgical and Long-term Oncological Outcomes of Totally Laparoscopic Near-total Gastrectomy in >150 Cases. Surg Laparosc Endosc Percutan Tech. 2020 Dec;30(6):529-533.
15) Alshehri A, Kim HS, Kim BS. Laparoscopic management of gastric remnant ischemia after laparoscopic distal gastrectomy with Billroth-I anastomosis-A case report. Int J Surg Case Rep. 2020;66:265-269.
16) Jeong GS, Lee IS, Park YS, Kim BS, Yoo MW, Yook JH, Kim BS. Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers. J Gastric Cancer. 2020 Sep;20(3):233-244.
17) Choi M, Ko CS, Yook JH, Kim BS, Kim BS. Comparative outcomes between totally laparoscopic total gastrectomy with the modified overlap method for early gastric cancer and advanced gastric cancer: review of 149 consecutive cases. Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):437-445
18) Choi YK, Kim DH, Gong EJ, Na HK, Ahn JY, Jung KW, Lee JH, Choi KD, Song HJ, Jung HY, Yook JH, Kim BS. Comparison Between Redo Endoscopic Treatment and Surgery in Patients with Locally Recurrent Gastric Neoplasms. J Gastrointest Surg. 2020 Jul;24(7):1489-1498.
19) Kim BS, Lee I, Yook JH, Song K, Kim BS. Association between the MUC1 rs4072037 Polymorphism and Risk of Gastric Cancer and Clinical Outcomes. J Gastric Cancer. 2020 Jun;20(2):127-138.
20) Kim A, Kim BS, Yook JH, Kim BS. Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer. World J Gastroenterol. 2020 May 14;26(18):2232-2246.
21) Lee K, Kim KW, Lee JB, Shin Y, Jang JK, Yook JH, Kim BS, Lee IS. Impact of remnant stomach volume and anastomosis on nutrition and body composition in gastric cancer patients. Surg Oncol. 2019 Dec:31:75-82.
22) Park SY, Lee IS, Kim A, Yook JH, Kim BS. Surgical Outcomes and Follow-Up Results of 100 Cases of Laparoscopic Total Gastrectomy Using the Overlap Method with Stapled Closure. J Minim Invasive Surg. 2019 Dec 15;22(4):150-156.
23) Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett. 2019 Sep;18(3):3031-3038.
24) Lee TH, Jin JO, Yu KJ, Kim HS, Lee PC. Inhibition of peroxiredoxin 2 suppresses Wnt/β-catenin signaling in gastric cancer. Biochem Biophys Res Commun. 2019 Apr 30;512(2):250-255.
25) Gong CS, Ko CS, Kim BS, Kim HS. Diaphragmatic Hernia After Totally Laparoscopic Total Gastrectomy for Gastric Cancer. Surg Laparosc Endosc Percutan Tech. 2019 Jun;29(3):194-199.
26) Choi BM, Ki SH, Lee YH, Gong CS, Kim HS, Lee IS, Kim BS, Kim BS, Noh GJ. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: A randomised controlled trial. Eur J Anaesthesiol. 2019 Nov;36(11):863-870.27) Kim HS, Won YJ, Shim JH, Kim HJ, Kim J, Hong HN, Kim BS. Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Sci Rep. 2019 Mar 4;9(1):3414.
28) Su Jung Choi, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim. Clinical Outcomes of Totally Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Remnant Gastric Cancer. Journal of Minimally Invasive Surgery 2019; 22(1): 29-38
29) Mun DG, Bhin J, Kim S, Kim H, Jung JH, Jung Y, Jang YE, Park JM, Kim H, Jung Y, Lee H, Bae J, Back S, Kim SJ, Kim J, Park H, Li H, Hwang KB, Park YS, Yook JH, Kim BS, Kwon SY, Ryu SW, Park DY, Jeon TY, Kim DH, Lee JH, Han SU, Song KS, Park D, Park JW, Rodriguez H, Kim J, Lee H, Kim KP, Yang EG, Kim HK, Paek E, Lee S, Lee SW, Hwang D. Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer Cell. 2019 Jan 14;35(1):111-124.
30) Kim JH, Ryu MH, Yoo C, Chae H, Na H, Beck M, Kim BS, Yoo MW, Yook JH, Kim BS, Kim KH, Kim CW, Kang YK. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Cancer Med. 2019 Mar;8(3):1034-1043.
31) Cho CJ, Jung J, Jiang L, Lee EJ, Kim DS, Kim BS, Kim HS, Jung HY, Song HJ, Hwang SW, Park Y, Jung MK, Pack CG, Myung SJ, Chang S. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Dig Dis Sci. 2018 Jul;63(7):1835-1850.
32) Hong HN, Won YJ, Shim JH, Kim HJ, Han SH, Kim BS, Kim HS. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner. J Cancer Res Clin Oncol. 2018 Sep;144(9):1649-1663.
33) Cho CJ, Jung J, Jiang L, Lee EJ, Kim DS, Kim BS, Kim HS, Jung HY, Song HJ, Hwang SW, Park Y, Jung MK, Pack CG, Myung SJ, Chang S. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Dig Dis Sci. 2018 Jul;63(7):1835-1850.
34) Eom SY, Yim DH, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018 Jul 23;32(4):257-263.
35) Lee IS, Kang HJ, Park YS, Ryu MH, Yook JH, Kang YK, Kim BS. Prognostic impact of extranodal extension in stage 1B gastric carcinomas. Surg Oncol. 2018 Jun;27(2):299-305.
36) Lee S, Choi KD, Han M, Na HK, Ahn JY, Jung KW, Lee JH, Kim DH, Song HJ, Lee GH, Yook JH, Kim BS, Jung HY. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer. 2018 May;21(3):490-499.
37) Gong EJ, Lee JY, Bae SE, Park YS, Choi KD, Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, Yook JH, Kim BS. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology. PLoS One. 2018 Apr 5;13(4):e0195264.
38) Kim JH, Park SR, Ryu MH, Ryoo BY, Kim KP, Kim BS, Yoo MW, Yook JH, Kim BS, Kim J, Byeon SJ, Kang YK. Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis. Cancer Res Treat. 2018 Apr;50(2):518-529.
39) Gong CS, Kim BS, Kim HS. Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience. World J Gastroenterol. 2017 Dec 28;23(48):8553-8561.
40) Kim HS, Ahn JY, Kim SO, Kim BS. Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc. 2017 Nov;31(11):4735-4748.
41) Cho H, Ryu MH, Kim KP, Ryoo BY, Park SR, Kim BS, Lee IS, Kim HS, Yoo MW, Yook JH, Oh ST, Kim BS, Kang YK. Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis. Gastric Cancer. 2017 Nov;20(6):970-977.
42) Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY. Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget. 2017 Oct 19;8(58):98887-98897.
43) Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, Ahn JY, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Kim BS, Yook JH, Kim BS. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017 Sep;20(5):793-801.
44) Lee TG, Lee IS, Yook JH, Kim BS. Totally laparoscopic total gastrectomy using the overlap method; early outcomes of 50 consecutive cases. Surg Endosc. 2017 Aug;31(8):3186-3190.
45) Cho SY, Park JW, Liu Y, Park YS, Kim JH, Yang H, Um H, Ko WR, Lee BI, Kwon SY, Ryu SW, Kwon CH, Park DY, Lee JH, Lee SI, Song KS, Hur H, Han SU, Chang H, Kim SJ, Kim BS, Yook JH, Yoo MW, Kim BS, Lee IS, Kook MC, Thiessen N, He A, Stewart C, Dunford A, Kim J, Shih J, Saksena G, Cherniack AD, Schumacher S, Weiner AT, Rosenberg M, Getz G, Yang EG, Ryu MH, Bass AJ, Kim HK. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Gastroenterology. 2017 Aug;153(2):536-549.
46) Jun SY, Son D, Kim MJ, Kim SJ, An S, Park YS, Park SR, Choi KD, Jung HY, Kim SC, Yook JH, Kim BS, Hong SM. Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases. Am J Surg Pathol. 2017 Jun;41(6):833-848.
47) Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD, Song HJ, Lee GH, Jung HY, Kim HS, Lee IS, Kim BS, Yoo MW, Oh ST, Yook JH, Kim BS. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer. 2017 Mar;20(Suppl 1):84-91.
48) Kim BS, Park YS, Yook JH, Kim BS. Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma. Therap Adv Gastroenterol. 2017 May;10(5):407-415.
49) Lee IS, Lee S, Park YS, Gong CS, Yook JH, Kim BS. Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis. Surg Oncol. 2017 Mar;26(1):8-12.
50) Suh DD, Oh ST, Yook JH, Kim BS, Kim BS. Differences in the prognosis of early gastric cancer according to sex and age. Therap Adv Gastroenterol. 2017 Feb;10(2):219-229.
51) Choi KH, Kim BS, Oh ST, Yook JH, Kim BS. Comparison the sixth and seventh editions of the AJCC staging system for T1 gastric cancer: a long-term follow-up study of 2124 patients. Gastric Cancer. 2017 Jan;20(1):43-48.
52) Lee IS, Ahn JY, Yook JH, Kim BS. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol. 2017 Jan 18;15(1):28.
53) Jeong JH, Park SR, Ahn Y, Ryu MH, Ryoo BY, Kong SY, Yook JH, Yoo MW, Kim BS, Kim BS, Kang YK. Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. Gastric Cancer. 2017 Jan;20(1):146-155.
54) Yoon S, Yoo C, Ryu MH, Kang MJ, Ryoo BY, Park SR, Yook JH, Oh ST, Yoo MW, Kim BS, Kang YK. Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer. Gastric Cancer. 2017 Jan;20(1):182-189.
55) Eom SY, Hong SM, Yim DH, Kwon HJ, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans. Cancer Med. 2016 Nov;5(11):3236-3335.
56) Gong CS, Yook JH, Oh ST, Kim BS. Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience. Ann Surg Treat Res
. 2016 Nov;91(5):219-225.
57) Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J, Chung C, Dawsey SM, Ding T, Gao YT, Giffen C, Han Y, Hong M, Huang J, Kim HS, Koh WP, Liao LM, Mao YM, Qiao YL, Shu XO, Tan W, Wang C, Wu C, Wu MJ, Xiang YB, Yeager M, Yook JH, Yuan JM, Zhang P, Zhao XK, Zheng W, Song K, Wang LD, Lin D, Chanock SJ, Goldstein AM, Taylor PR, Abnet CC. Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2016 Oct;65(10):1611-8.
58) Kang HJ, Lee IS, Park YS, Ho WJ, Sohn D, Ahn JY, Yook JH, Kim BS.
Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Ann Surg Oncol. 2016 Oct;23(11):3684-3692.
59) Huh J, Lee IS, Kim KW, Park J, Kim AY, Lee JS, Yook JH, Kim BS. CT gastrography for volumetric measurement of remnant stomach after distal gastrectomy: a feasibility study. Abdom Radiol (NY). 2016. Oct;41(10):1899-905.
60) Song MJ, Park YS, Song HJ, Park SJ, Ahn JY, Choi KD, Lee GH, Jung HY, Yook JH, Kim BS. Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver. 2016 Sep 15;10(5):731-8.
61) Kim BS, Park YS, Yook JH, Kim BS. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors. Medicine (Baltimore). 2016 Jul;95(30):e3977.
62) Gong CS, Yoo MW, Kim BS, Hwang S, Kim KH, Yook JH, Kim BS, Lee SG. De Novo Gastric Cancer After Liver Transplantation. Ann Transplant. 2016 Jun 23:21:386-91.
63) Lee S, Ahn JY, Jung HY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH, Kim BS, Yook JH, Oh ST, Kim BS. Clinical Outcomes of Postoperative Upper Gastrointestinal Leakage According to Treatment Modality. Dig Dis Sci. 2016 Feb;61(2):523-32.
64) Park JH, Ryu MH, Kim HJ, Ryoo BY, Yoo C, Park I, Park YS, Oh ST, Yook JH, Kim BS, Kang YK. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer. Gastric Cancer. 2016 Jan;19(1):226-33.
65) Kim HS, Kim SO, Kim BS. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World J Gastroenterol. 2015 Dec. 28;21(48):13507-17.
66) Yoo C, Koh YW, Park YS, Ryu MH, Ryoo BY, Park HJ, Yook JH, Kim BS, Kang YK. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S362-9.
67) Kim BS, Park YS, Yook JH, Oh ST, Kim BS. Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme. Medicine (Baltimore). 2015 Nov;94(44).
68) Lim H, Park YS, Lee JH, Son DH, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Yook JH, Kim BS. Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol. 2015 Oct;13(10):1738-1744
69) Yoo C, Ryu MH, Park YS, Yoo MW, Park SR, Ryoo BY, Jang SJ, Yook JH, Kim BS, Kang YK. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence. Ann Surg Oncol. 2015 Sep;22(9):2940-7.
70) Kim BS, Yook JH, Kim BS, Jung HY. A simplified technique for tumor localization using preoperative endoscopic clipping and radio-opaque markers during totally laparoscopic gastrectomy. Am Surg. 2014 Dec;80(12):1266-70.
71) Park SJ, Ryu MH, Ryoo BY, Park YS, Sohn BS, Kim HJ, Kim CW, Kim KH, Yu CS, Yook JH, Kim BS, Kang YK. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses. Ann Surg Oncol. 2014 Dec;21(13):4211-7.
72) Park JY, Ryu MH, Park YS, Park HJ, Ryoo BY, Kim MG, Yook JH, Kim BS, Kang YK. Prognostic significance of neuroendocrine components in gastric carcinomas. Eur J Cancer. 2014 Nov;50(16):2802-9.
73) Kim BS, Oh ST, Yook JH, Kim BS. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer. Surgery. 2014 Jun;155(6):1030-5.
74) Park JH, Song HY, Kim SH, Shin JH, Kim JH, Kim BS, Yook JH. Metallic stent placement in patients with recurrent malignant obstruction in the surgically altered stomach. Ann Surg Oncol. 2014 Jun;21(6):2036-43.
75) Kim BS, Oh ST, Yook JH, Kim HS, Lee IS, Kim BS. Appropriate gastrectomy resection margins for early gastric carcinoma. Surg Oncol. 2014 Mar;109(3):198-201.
76) Kim BS, Oh ST, Yook JH, Kim BS. What is the appropriate management for perforated gastric cancer? Am Surg. 2014 May;80(5):517-20.
77) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Laparoscopic gastrectomy in patients with previous gastrectomy for gastric cancer: a report of 17 cases. Surg Laparosc Endosc Percutan Tech. 2014 Apr;24(2):177-82.
78) Kang YK, Yook JH, Chang HM, Ryu MH, Yoo C, Zang DY, Lee JL, Kim TW, Yang DH, Jang SJ, Park YS, Lee YJ, Jung HY, Kim JH, Kim BS. Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).
Cancer Chemother Pharmacol. 2014 Jan;73(1):139-49.
79) Kim HS, Kim BS, Lee S, Lee IS, Yook JH, Kim BS. Reconstruction of esophagojejunostomies using endoscopic linear staplers in totally laparoscopic total gastrectomy: report of 139 cases in a large-volume center. Surg Laparosc Endosc Percutan Tech. 2013 Dec;23(6):e209-16.
80) Jo JC, Ryu MH, Koo DH, Ryoo BY, Kim HJ, Kim TW, Choi KD, Lee GH, Jung HY, Yook JH, Oh ST, Kim BS, Kim JH, Kang YK. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol. 2013 Dec;9(4):324-30.
81) Lee IS, Park YS, Lee JH, Park JY, Kim HS, Kim BS, Yook JH, Oh ST, Kim BS. Pathologic discordance of differentiation between endoscopic biopsy and postoperative specimen in mucosal gastric adenocarcinomas. Ann Surg Oncol. 2013 Dec;20(13):4231-7.
82) An HJ, Ryu MH, Ryoo BY, Sohn BS, Kim KH, Oh ST, Yu CS, Yook JH, Kim BS, Kang YK. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Ann Surg Oncol. 2013 Dec;20(13):4212-8.
83) Lee S, Ahn JY, Jung HY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH, Kim BS, Yook JH, Oh ST, Kim BS, Han S. Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage. Surg Endosc. 2013 Nov;27(11):4232-40.
84) Kim MG, Kim HS, Kim BS, Kwon SJ. The impact of old age on surgical outcomes of totally laparoscopic gastrectomy for gastric cancer. Surg Endosc. 2013 Nov;27(11):3990-7.
85) Park I, Ryu MH, Choi YH, Kang HJ, Yook JH, Park YS, Kim HJ, Jung HY, Lee GH, Kim KC, Kim BS, Kang YK. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. Cancer Chemother Pharmacol. 2013 Oct;72(4):815-23.
86) Kim BS, Oh ST, Yook JH, Park YS, Kim BS. Primary small cell carcinoma of the stomach: clinical outcomes and prognoses. Am Surg. 2013 Sep;79(9):e305-7.
87) Koh YW, Park YS, Ryu MH, Ryoo BY, Park HJ, Yook JH, Kim BS, Kang YK. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Am J Surg Pathol. 2013 Jul;37(7):1022-9.
88) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Analysis of predictive risk factors for postoperative complications of laparoscopy-assisted distal gastrectomy. J Laparoendosc Adv Surg Tech A. 2013 May;23(5):425-30.
89) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Comparison of totally laparoscopic total gastrectomy and laparoscopic-assisted total gastrectomy methods for the surgical treatment of early gastric cancer near the gastroesophageal junction. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):204-10.
90) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Intracorporeal laparoscopic Roux-en-Y gastrojejunostomy after 95% gastrectomy for early gastric cancer in the upper third of the stomach: a report on 21 cases. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):250-7.
91) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A. 2013 Apr;23(4):323-31.
92) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Laparoscopic surgery for submucosal tumor near the esophagogastric junction. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):225-30.
93) Lee IS, Kim TH, Yook JH, Kim HS, Kim BS, Kim BS. A triangle method: simple suture retraction for the left lobe of the liver during laparoscopic gastric surgery. J Laparoendosc Adv Surg Tech A. 2012 Dec;22(10):989-91.
94) Lee IS, Park YS, Kim KC, Kim TH, Kim HS, Choi KD, Lee GH, Yook JH, Oh ST, Kim BS. Multiple synchronous early gastric cancers: high-risk group and proper management. Surg Oncol. 2012 Dec;21(4):269-73.
95) Lee IS, Kim TH, Kim KC, Yook JH, Kim BS. Modified techniques and early outcomes of totally laparoscopic total gastrectomy with side-to-side esophagojejunostomy. J Laparoendosc Adv Surg Tech A. 2012 Nov;22(9):876-80.
96) Kim HS, Kim MG, Kim BS, Yook JH, Kim BS.Totally laparoscopic total gastrectomy using endoscopic linear stapler: early experiences at one institute. J Laparoendosc Adv Surg Tech A. 2012 Nov;22(9):889-97.
97) Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, Kang YK. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer. Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9.
98) Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med. 2012 Oct 3;12:172.
99) Lee IS, Kim TH, Kim YH, Yook JH, Kim BS, Han DJ. Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg. 2012 Aug;36(8):1806-10.
100) Park YS, Hwang HS, Park HJ, Ryu MH, Chang HM, Yook JH, Kim BS, Jang SJ, Kang YK. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Hum Pathol. 2012 Mar;43(3):413-22.
101) Hwang S, Hong HN, Kim HS, Park SR, Won YJ, Choi ST, Choi D, Lee SG. Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int. 2012 Mar 1;36(3):279-88.
102) Kim MY, Park YS, Choi KD, Lee JH, Choi KS, Kim DH, Song HJ, Lee GH, Jung HY, Kim JH, Yun SC, Kim KC, Yook JH, Oh ST, Kim BS, Ryu MH, Kang YK. Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less J Clin Gastroenterol. 2012 Feb;46(2):130-7.
103) Lee JH, Choi KD, Kim MY, Choi KS, Kim DH, Park YS, Kim KC, Song HJ, Lee GH, Jung HY, Yook JH, Kim BS, Kang YK, Kim JH. Clinical impact of EUS-guided Trucut biopsy results on decision making for patients with gastric subepithelial tumors ≥ 2 cm in diameter.
Gastrointest Endosc. 2011 Nov;74(5):1010-8.
104) Kim KC, Koh YW, Chang HM, Kim TH, Yook JH, Kim BS, Jang SJ, Park YS. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Ann Surg Oncol. 2011 Oct;18(10):2833-40.
105) Kim BS, Yook JH, Choi YB, Kim KC, Kim MG, Kim TH, Kawada H, Kim BS. Comparison of early outcomes of intracorporeal and extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A. 2011 Jun;21(5):387-91.
106) Kang YK, Ryu MH, Yoo C, Chang HM, Yook JH, Oh ST, Kim BS, Kim TW. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2011 Jun;67(6):1435-43.
107) Kim MG, Yook JH, Kim KC, Kim TH, Kim HS, Kim BS, Kim BS. Influence of obesity on early surgical outcomes of laparoscopic-assisted gastrectomy in gastric cancer. Surg Laparosc Endosc Percutan Tech. 2011 Jun;21(3):151-4.
108) Kim MG, Kim KC, Kim BS, Kim TH, Kim HS, Yook JH, Kim BS. A totally laparoscopic distal gastrectomy can be an effective way of performing laparoscopic gastrectomy in obese patients (body mass index≥30). World J Surg. 2011 Jun;35(6):1327-32.
109) Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, Lee JH, Kim MY, Kim BS, Oh ST, Yook JH, Jang SJ, Yun SC, Kim SO, Kim JH. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc. 2011 May;73(5):942-8.
110) Chung JW, Jung HY, Choi KD, Song HJ, Lee GH, Jang SJ, Park YS, Yook JH, Oh ST, Kim BS, Kim JH. Extended indication of endoscopic resection for mucosal early gastric cancer: analysis of a single center experience. J Gastroenterol Hepatol. 2011 May;26(5):884-7.
111) Kim MG, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc. 2011 Apr;80(4):245-50.
112) Kim MG, Kawada H, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. A totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG) for improvement of the early surgical outcomes in high BMI patients. Surg Endosc. 2011 Apr;25(4):1076-82.
113) Kim BS, Oh ST, Yook JH, Kim KC, Kim MG, Jeong JW, Kim BS. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am J Surg. 2010 Sep;200(3):328-33.
114) Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Cancer Chemother Pharmacol. 2010 Jul;66(2):373-80.
115) Kim JH, Song HY, Hu HT, Kang YK, Jung HY, Yook JH, Kim BS. Palliative treatment of malignant gastric outlet obstructions with a large-diameter metallic stent: prospective preliminary study. J Vasc Interv Radiol. 2010 Jul;21(7):1125-8.
116) Yoon SN, Roh SA, Cho DH, Kim MB, Hyun YL, Ro S, Kim BS, Kim SY, Kim YS, Kim JC. In vitro chemosensitivity of gastric adenocarcinomas to histone deacetylase inhibitors, compared to established drugs. Hepatogastroenterology. 2010 May-Jun;57(99-100):657-62.
117) Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.
Ann Surg Oncol. 2010 Apr;17(4):1024-32.
118) Sym SJ, Chang HM, Kang HJ, Lee SS, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer. Cancer Chemother Pharmacol. 2008 Dec;63(1):1-8.
119) Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Kim HC, Kim KH, Yook JH, Kim BS, Kang YK. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs). J Surg Oncol. 2008 Jul 1;98(1):27-33.
120) Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 2008 Jul;15(7):1968-76.
121) Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7.
122) Kim JH, Song HY, Park SW, Yoon CJ, Shin JH, Yook JH, Kim BS. Early symptomatic strictures after gastric surgery: palliation with balloon dilation and stent placement. J Vasc Interv Radiol. 2008 Apr;19(4):565-70.
123) Chang HM, Ryu MH, Lee H, Jang SJ, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors. Oncology. 2008;74(1-2):88-95.
124) Song HY, Kim TH, Choi EK, Kim JH, Kim KR, Shin JH, Lee SK, Kim TW, Yook JH, Kim BS. Metallic stent placement in patients with recurrent cancer after gastrojejunostomy. J Vasc Interv Radiol. 2007 Dec;18(12):1538-46.
125) Yang ZQ, Song HY, Kim JH, Shin JH, Kim TW, Yook JH, Kim BS. Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction. J Vasc Interv Radiol. 2007 Dec;18(12):1533-7.
126) Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, Lee GH, Lee SK, Kim MH, Ryu MH, Kang YK, Kim BS, Yook JH. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc. 2007 Aug;66(2):256-64.
127) Kim JH, Song HY, Shin JH, Choi E, Kim TW, Lee SK, Kim BS. Stent collapse as a delayed complication of placement of a covered gastroduodenal stent. AJR Am J Roentgenol. 2007 Jun;188(6):1495-9.
128) Kim KH, Kim HS, Lee YJ, Park KM, Hwang S, Ahn CS, Moon DB, Ha TY, Kim YD, Kim KK, Song KW, Choi ST, Kim DS, Jung DH, Lee SG. Clinical analysis of right anterior segmentectomy for hepatic malignancy. Hepatogastroenterology. 2006 Nov-Dec;53(72):836-9.
129) Oh JS, Lee JL, Kim MJ, Ryu MH, Chang HM, Kim TW, Jang SJ, Yook JH, Oh ST, Kim BS, Kang YK. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases. Cancer Res Treat. 2006;38(3):178-83.
130) Kim HC, Kim JC, Roh SA, Yu CS, Yook JH, Oh ST, Kim BS, Park KC, Chang R. Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol. 2005 Nov;131(11):733-40.
131) Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapy. Cancer Res Treat. 2005 Aug;37(4):201-7.
132) Song HY, Shin JH, Yoon CJ, Lee GH, Kim TW, Lee SK, Yook JH, Kim BS. A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures. J Vasc Interv Radiol. 2004 Dec;15(12):1443-9.
133) Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res. 2004 May 1;10(9):3076-81.
2) Chang Seok Ko, Jin Ho Jheong, Seong-A Jeong, Byung Sik Kim, Jeong Hwan Yook, Moon-Won Yoo, Beom Su Kim, In-Seob Lee, Sehee Kim, Chung Sik Gong. Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer. Ann Surg Oncol. 2022 Aug;29(8):5076-5082.
3) Chang Seok Ko, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim 4A comparative study of laparoscopic near-total and total gastrectomy for patient nutritional status and quality of life using a propensity score matching analysis. 2022 Aug;36(8):5610-5617.
4) So S, Noh JH, Ahn JY, Lee IS, Lee JB, Jung HY, Yook JH, Kim BS. Scoring Model Based on Nodal Metastasis Prediction Suggesting an Alternative Treatment to Total Gastrectomy in Proximal Early Gastric Cancer. J Gastric Cancer. 2022 Mar;22(1):24-34.
5) Ko CS, Jheong JH, Jeong SA, Gong CS, Lee IS, Kim BS, Kim BS, Park HS, Min SH, Yoo MW. Early Clinical Outcomes of the Morbidly Obese Patients Who Underwent Laparoscopic Sleeve Gastrectomy by Gastric Cancer Surgeons: the Analysis of Fifty Consecutive Cases. J Metab Bariatr Surg. 2021 Dec;10(2):66-73
6) Ko CS, Choi NR, Kim BS, Yook JH, Kim MJ, Kim BS. Totally laparoscopic total gastrectomy using the modified overlap method and conventional open total gastrectomy: A comparative study. World J Gastroenterol. 2021 May 14;27(18):2193-2204.
7) Lee IS, Sahu D, Hur H, Yook JH, Kim BS, Goel A. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer. Gastric Cancer. 2021 May;24(3):655-665.
8) Lee IS, Lee H, Hur H, Kanda M, Yook JH, Kim BS, Woo Y, Kodera Y, Kim K, Goel A. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer. Clin Cancer Res. 2021 Apr 15;27(8):2292-2300.
9) Amy Kim, Chang Seok Ko, Hee Sung Kim, Byung Sik Kim. Intracorporeal bi-directional pouch jejunojejunostomy following Roux-en-Y anastomosis: A simple reconstruction technique using an endoscopic linear stapler. Videosurgery and other miniinvasive techniques. 2021 Apr 30;16(4):704–709.
10) Choi NY, Kim BS, Oh ST, Yook JH, Kim BS. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach. Am Surg. 2021 Apr;87(4):631-637.
11) Shin E, Bae S, Jung J, Song WJ, Kwon HS, Kim HS, Kim SH, Kim TB, Cho YS, Lee JH. Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine. Allergy. 2021 Jun 15.
12) Kim KW, Lee K, Lee JB, Park T, Khang S, Jeong H, Ko CS, Yook JH, Kim BS, Lee IS. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study. BMC Cancer. 2021 Feb 12;21(1):157.
13) Chang Seok Ko, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim. Overlap method versus functional method for esophagojejunal reconstruction using totally laparoscopic total gastrectomy. Surg Endosc. 2021 Jan;35(1):130-138.
14) Shin EJ, Gong CS, Kim BS, Kim SO, Ko CS, Kim HS. Early Surgical and Long-term Oncological Outcomes of Totally Laparoscopic Near-total Gastrectomy in >150 Cases. Surg Laparosc Endosc Percutan Tech. 2020 Dec;30(6):529-533.
15) Alshehri A, Kim HS, Kim BS. Laparoscopic management of gastric remnant ischemia after laparoscopic distal gastrectomy with Billroth-I anastomosis-A case report. Int J Surg Case Rep. 2020;66:265-269.
16) Jeong GS, Lee IS, Park YS, Kim BS, Yoo MW, Yook JH, Kim BS. Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers. J Gastric Cancer. 2020 Sep;20(3):233-244.
17) Choi M, Ko CS, Yook JH, Kim BS, Kim BS. Comparative outcomes between totally laparoscopic total gastrectomy with the modified overlap method for early gastric cancer and advanced gastric cancer: review of 149 consecutive cases. Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):437-445
18) Choi YK, Kim DH, Gong EJ, Na HK, Ahn JY, Jung KW, Lee JH, Choi KD, Song HJ, Jung HY, Yook JH, Kim BS. Comparison Between Redo Endoscopic Treatment and Surgery in Patients with Locally Recurrent Gastric Neoplasms. J Gastrointest Surg. 2020 Jul;24(7):1489-1498.
19) Kim BS, Lee I, Yook JH, Song K, Kim BS. Association between the MUC1 rs4072037 Polymorphism and Risk of Gastric Cancer and Clinical Outcomes. J Gastric Cancer. 2020 Jun;20(2):127-138.
20) Kim A, Kim BS, Yook JH, Kim BS. Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer. World J Gastroenterol. 2020 May 14;26(18):2232-2246.
21) Lee K, Kim KW, Lee JB, Shin Y, Jang JK, Yook JH, Kim BS, Lee IS. Impact of remnant stomach volume and anastomosis on nutrition and body composition in gastric cancer patients. Surg Oncol. 2019 Dec:31:75-82.
22) Park SY, Lee IS, Kim A, Yook JH, Kim BS. Surgical Outcomes and Follow-Up Results of 100 Cases of Laparoscopic Total Gastrectomy Using the Overlap Method with Stapled Closure. J Minim Invasive Surg. 2019 Dec 15;22(4):150-156.
23) Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett. 2019 Sep;18(3):3031-3038.
24) Lee TH, Jin JO, Yu KJ, Kim HS, Lee PC. Inhibition of peroxiredoxin 2 suppresses Wnt/β-catenin signaling in gastric cancer. Biochem Biophys Res Commun. 2019 Apr 30;512(2):250-255.
25) Gong CS, Ko CS, Kim BS, Kim HS. Diaphragmatic Hernia After Totally Laparoscopic Total Gastrectomy for Gastric Cancer. Surg Laparosc Endosc Percutan Tech. 2019 Jun;29(3):194-199.
26) Choi BM, Ki SH, Lee YH, Gong CS, Kim HS, Lee IS, Kim BS, Kim BS, Noh GJ. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: A randomised controlled trial. Eur J Anaesthesiol. 2019 Nov;36(11):863-870.27) Kim HS, Won YJ, Shim JH, Kim HJ, Kim J, Hong HN, Kim BS. Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Sci Rep. 2019 Mar 4;9(1):3414.
28) Su Jung Choi, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Hee Sung Kim. Clinical Outcomes of Totally Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Remnant Gastric Cancer. Journal of Minimally Invasive Surgery 2019; 22(1): 29-38
29) Mun DG, Bhin J, Kim S, Kim H, Jung JH, Jung Y, Jang YE, Park JM, Kim H, Jung Y, Lee H, Bae J, Back S, Kim SJ, Kim J, Park H, Li H, Hwang KB, Park YS, Yook JH, Kim BS, Kwon SY, Ryu SW, Park DY, Jeon TY, Kim DH, Lee JH, Han SU, Song KS, Park D, Park JW, Rodriguez H, Kim J, Lee H, Kim KP, Yang EG, Kim HK, Paek E, Lee S, Lee SW, Hwang D. Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer Cell. 2019 Jan 14;35(1):111-124.
30) Kim JH, Ryu MH, Yoo C, Chae H, Na H, Beck M, Kim BS, Yoo MW, Yook JH, Kim BS, Kim KH, Kim CW, Kang YK. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Cancer Med. 2019 Mar;8(3):1034-1043.
31) Cho CJ, Jung J, Jiang L, Lee EJ, Kim DS, Kim BS, Kim HS, Jung HY, Song HJ, Hwang SW, Park Y, Jung MK, Pack CG, Myung SJ, Chang S. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Dig Dis Sci. 2018 Jul;63(7):1835-1850.
32) Hong HN, Won YJ, Shim JH, Kim HJ, Han SH, Kim BS, Kim HS. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner. J Cancer Res Clin Oncol. 2018 Sep;144(9):1649-1663.
33) Cho CJ, Jung J, Jiang L, Lee EJ, Kim DS, Kim BS, Kim HS, Jung HY, Song HJ, Hwang SW, Park Y, Jung MK, Pack CG, Myung SJ, Chang S. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Dig Dis Sci. 2018 Jul;63(7):1835-1850.
34) Eom SY, Yim DH, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018 Jul 23;32(4):257-263.
35) Lee IS, Kang HJ, Park YS, Ryu MH, Yook JH, Kang YK, Kim BS. Prognostic impact of extranodal extension in stage 1B gastric carcinomas. Surg Oncol. 2018 Jun;27(2):299-305.
36) Lee S, Choi KD, Han M, Na HK, Ahn JY, Jung KW, Lee JH, Kim DH, Song HJ, Lee GH, Yook JH, Kim BS, Jung HY. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer. 2018 May;21(3):490-499.
37) Gong EJ, Lee JY, Bae SE, Park YS, Choi KD, Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, Yook JH, Kim BS. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology. PLoS One. 2018 Apr 5;13(4):e0195264.
38) Kim JH, Park SR, Ryu MH, Ryoo BY, Kim KP, Kim BS, Yoo MW, Yook JH, Kim BS, Kim J, Byeon SJ, Kang YK. Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis. Cancer Res Treat. 2018 Apr;50(2):518-529.
39) Gong CS, Kim BS, Kim HS. Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience. World J Gastroenterol. 2017 Dec 28;23(48):8553-8561.
40) Kim HS, Ahn JY, Kim SO, Kim BS. Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc. 2017 Nov;31(11):4735-4748.
41) Cho H, Ryu MH, Kim KP, Ryoo BY, Park SR, Kim BS, Lee IS, Kim HS, Yoo MW, Yook JH, Oh ST, Kim BS, Kang YK. Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis. Gastric Cancer. 2017 Nov;20(6):970-977.
42) Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY. Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget. 2017 Oct 19;8(58):98887-98897.
43) Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, Ahn JY, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Kim BS, Yook JH, Kim BS. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017 Sep;20(5):793-801.
44) Lee TG, Lee IS, Yook JH, Kim BS. Totally laparoscopic total gastrectomy using the overlap method; early outcomes of 50 consecutive cases. Surg Endosc. 2017 Aug;31(8):3186-3190.
45) Cho SY, Park JW, Liu Y, Park YS, Kim JH, Yang H, Um H, Ko WR, Lee BI, Kwon SY, Ryu SW, Kwon CH, Park DY, Lee JH, Lee SI, Song KS, Hur H, Han SU, Chang H, Kim SJ, Kim BS, Yook JH, Yoo MW, Kim BS, Lee IS, Kook MC, Thiessen N, He A, Stewart C, Dunford A, Kim J, Shih J, Saksena G, Cherniack AD, Schumacher S, Weiner AT, Rosenberg M, Getz G, Yang EG, Ryu MH, Bass AJ, Kim HK. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Gastroenterology. 2017 Aug;153(2):536-549.
46) Jun SY, Son D, Kim MJ, Kim SJ, An S, Park YS, Park SR, Choi KD, Jung HY, Kim SC, Yook JH, Kim BS, Hong SM. Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases. Am J Surg Pathol. 2017 Jun;41(6):833-848.
47) Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD, Song HJ, Lee GH, Jung HY, Kim HS, Lee IS, Kim BS, Yoo MW, Oh ST, Yook JH, Kim BS. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer. 2017 Mar;20(Suppl 1):84-91.
48) Kim BS, Park YS, Yook JH, Kim BS. Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma. Therap Adv Gastroenterol. 2017 May;10(5):407-415.
49) Lee IS, Lee S, Park YS, Gong CS, Yook JH, Kim BS. Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis. Surg Oncol. 2017 Mar;26(1):8-12.
50) Suh DD, Oh ST, Yook JH, Kim BS, Kim BS. Differences in the prognosis of early gastric cancer according to sex and age. Therap Adv Gastroenterol. 2017 Feb;10(2):219-229.
51) Choi KH, Kim BS, Oh ST, Yook JH, Kim BS. Comparison the sixth and seventh editions of the AJCC staging system for T1 gastric cancer: a long-term follow-up study of 2124 patients. Gastric Cancer. 2017 Jan;20(1):43-48.
52) Lee IS, Ahn JY, Yook JH, Kim BS. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol. 2017 Jan 18;15(1):28.
53) Jeong JH, Park SR, Ahn Y, Ryu MH, Ryoo BY, Kong SY, Yook JH, Yoo MW, Kim BS, Kim BS, Kang YK. Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. Gastric Cancer. 2017 Jan;20(1):146-155.
54) Yoon S, Yoo C, Ryu MH, Kang MJ, Ryoo BY, Park SR, Yook JH, Oh ST, Yoo MW, Kim BS, Kang YK. Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer. Gastric Cancer. 2017 Jan;20(1):182-189.
55) Eom SY, Hong SM, Yim DH, Kwon HJ, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans. Cancer Med. 2016 Nov;5(11):3236-3335.
56) Gong CS, Yook JH, Oh ST, Kim BS. Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience. Ann Surg Treat Res
. 2016 Nov;91(5):219-225.
57) Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J, Chung C, Dawsey SM, Ding T, Gao YT, Giffen C, Han Y, Hong M, Huang J, Kim HS, Koh WP, Liao LM, Mao YM, Qiao YL, Shu XO, Tan W, Wang C, Wu C, Wu MJ, Xiang YB, Yeager M, Yook JH, Yuan JM, Zhang P, Zhao XK, Zheng W, Song K, Wang LD, Lin D, Chanock SJ, Goldstein AM, Taylor PR, Abnet CC. Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2016 Oct;65(10):1611-8.
58) Kang HJ, Lee IS, Park YS, Ho WJ, Sohn D, Ahn JY, Yook JH, Kim BS.
Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Ann Surg Oncol. 2016 Oct;23(11):3684-3692.
59) Huh J, Lee IS, Kim KW, Park J, Kim AY, Lee JS, Yook JH, Kim BS. CT gastrography for volumetric measurement of remnant stomach after distal gastrectomy: a feasibility study. Abdom Radiol (NY). 2016. Oct;41(10):1899-905.
60) Song MJ, Park YS, Song HJ, Park SJ, Ahn JY, Choi KD, Lee GH, Jung HY, Yook JH, Kim BS. Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver. 2016 Sep 15;10(5):731-8.
61) Kim BS, Park YS, Yook JH, Kim BS. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors. Medicine (Baltimore). 2016 Jul;95(30):e3977.
62) Gong CS, Yoo MW, Kim BS, Hwang S, Kim KH, Yook JH, Kim BS, Lee SG. De Novo Gastric Cancer After Liver Transplantation. Ann Transplant. 2016 Jun 23:21:386-91.
63) Lee S, Ahn JY, Jung HY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH, Kim BS, Yook JH, Oh ST, Kim BS. Clinical Outcomes of Postoperative Upper Gastrointestinal Leakage According to Treatment Modality. Dig Dis Sci. 2016 Feb;61(2):523-32.
64) Park JH, Ryu MH, Kim HJ, Ryoo BY, Yoo C, Park I, Park YS, Oh ST, Yook JH, Kim BS, Kang YK. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer. Gastric Cancer. 2016 Jan;19(1):226-33.
65) Kim HS, Kim SO, Kim BS. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World J Gastroenterol. 2015 Dec. 28;21(48):13507-17.
66) Yoo C, Koh YW, Park YS, Ryu MH, Ryoo BY, Park HJ, Yook JH, Kim BS, Kang YK. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S362-9.
67) Kim BS, Park YS, Yook JH, Oh ST, Kim BS. Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme. Medicine (Baltimore). 2015 Nov;94(44).
68) Lim H, Park YS, Lee JH, Son DH, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Yook JH, Kim BS. Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol. 2015 Oct;13(10):1738-1744
69) Yoo C, Ryu MH, Park YS, Yoo MW, Park SR, Ryoo BY, Jang SJ, Yook JH, Kim BS, Kang YK. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence. Ann Surg Oncol. 2015 Sep;22(9):2940-7.
70) Kim BS, Yook JH, Kim BS, Jung HY. A simplified technique for tumor localization using preoperative endoscopic clipping and radio-opaque markers during totally laparoscopic gastrectomy. Am Surg. 2014 Dec;80(12):1266-70.
71) Park SJ, Ryu MH, Ryoo BY, Park YS, Sohn BS, Kim HJ, Kim CW, Kim KH, Yu CS, Yook JH, Kim BS, Kang YK. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses. Ann Surg Oncol. 2014 Dec;21(13):4211-7.
72) Park JY, Ryu MH, Park YS, Park HJ, Ryoo BY, Kim MG, Yook JH, Kim BS, Kang YK. Prognostic significance of neuroendocrine components in gastric carcinomas. Eur J Cancer. 2014 Nov;50(16):2802-9.
73) Kim BS, Oh ST, Yook JH, Kim BS. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer. Surgery. 2014 Jun;155(6):1030-5.
74) Park JH, Song HY, Kim SH, Shin JH, Kim JH, Kim BS, Yook JH. Metallic stent placement in patients with recurrent malignant obstruction in the surgically altered stomach. Ann Surg Oncol. 2014 Jun;21(6):2036-43.
75) Kim BS, Oh ST, Yook JH, Kim HS, Lee IS, Kim BS. Appropriate gastrectomy resection margins for early gastric carcinoma. Surg Oncol. 2014 Mar;109(3):198-201.
76) Kim BS, Oh ST, Yook JH, Kim BS. What is the appropriate management for perforated gastric cancer? Am Surg. 2014 May;80(5):517-20.
77) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Laparoscopic gastrectomy in patients with previous gastrectomy for gastric cancer: a report of 17 cases. Surg Laparosc Endosc Percutan Tech. 2014 Apr;24(2):177-82.
78) Kang YK, Yook JH, Chang HM, Ryu MH, Yoo C, Zang DY, Lee JL, Kim TW, Yang DH, Jang SJ, Park YS, Lee YJ, Jung HY, Kim JH, Kim BS. Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).
Cancer Chemother Pharmacol. 2014 Jan;73(1):139-49.
79) Kim HS, Kim BS, Lee S, Lee IS, Yook JH, Kim BS. Reconstruction of esophagojejunostomies using endoscopic linear staplers in totally laparoscopic total gastrectomy: report of 139 cases in a large-volume center. Surg Laparosc Endosc Percutan Tech. 2013 Dec;23(6):e209-16.
80) Jo JC, Ryu MH, Koo DH, Ryoo BY, Kim HJ, Kim TW, Choi KD, Lee GH, Jung HY, Yook JH, Oh ST, Kim BS, Kim JH, Kang YK. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol. 2013 Dec;9(4):324-30.
81) Lee IS, Park YS, Lee JH, Park JY, Kim HS, Kim BS, Yook JH, Oh ST, Kim BS. Pathologic discordance of differentiation between endoscopic biopsy and postoperative specimen in mucosal gastric adenocarcinomas. Ann Surg Oncol. 2013 Dec;20(13):4231-7.
82) An HJ, Ryu MH, Ryoo BY, Sohn BS, Kim KH, Oh ST, Yu CS, Yook JH, Kim BS, Kang YK. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Ann Surg Oncol. 2013 Dec;20(13):4212-8.
83) Lee S, Ahn JY, Jung HY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH, Kim BS, Yook JH, Oh ST, Kim BS, Han S. Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage. Surg Endosc. 2013 Nov;27(11):4232-40.
84) Kim MG, Kim HS, Kim BS, Kwon SJ. The impact of old age on surgical outcomes of totally laparoscopic gastrectomy for gastric cancer. Surg Endosc. 2013 Nov;27(11):3990-7.
85) Park I, Ryu MH, Choi YH, Kang HJ, Yook JH, Park YS, Kim HJ, Jung HY, Lee GH, Kim KC, Kim BS, Kang YK. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. Cancer Chemother Pharmacol. 2013 Oct;72(4):815-23.
86) Kim BS, Oh ST, Yook JH, Park YS, Kim BS. Primary small cell carcinoma of the stomach: clinical outcomes and prognoses. Am Surg. 2013 Sep;79(9):e305-7.
87) Koh YW, Park YS, Ryu MH, Ryoo BY, Park HJ, Yook JH, Kim BS, Kang YK. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Am J Surg Pathol. 2013 Jul;37(7):1022-9.
88) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Analysis of predictive risk factors for postoperative complications of laparoscopy-assisted distal gastrectomy. J Laparoendosc Adv Surg Tech A. 2013 May;23(5):425-30.
89) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Comparison of totally laparoscopic total gastrectomy and laparoscopic-assisted total gastrectomy methods for the surgical treatment of early gastric cancer near the gastroesophageal junction. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):204-10.
90) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Intracorporeal laparoscopic Roux-en-Y gastrojejunostomy after 95% gastrectomy for early gastric cancer in the upper third of the stomach: a report on 21 cases. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):250-7.
91) Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A. 2013 Apr;23(4):323-31.
92) Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, Kim BS. Laparoscopic surgery for submucosal tumor near the esophagogastric junction. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):225-30.
93) Lee IS, Kim TH, Yook JH, Kim HS, Kim BS, Kim BS. A triangle method: simple suture retraction for the left lobe of the liver during laparoscopic gastric surgery. J Laparoendosc Adv Surg Tech A. 2012 Dec;22(10):989-91.
94) Lee IS, Park YS, Kim KC, Kim TH, Kim HS, Choi KD, Lee GH, Yook JH, Oh ST, Kim BS. Multiple synchronous early gastric cancers: high-risk group and proper management. Surg Oncol. 2012 Dec;21(4):269-73.
95) Lee IS, Kim TH, Kim KC, Yook JH, Kim BS. Modified techniques and early outcomes of totally laparoscopic total gastrectomy with side-to-side esophagojejunostomy. J Laparoendosc Adv Surg Tech A. 2012 Nov;22(9):876-80.
96) Kim HS, Kim MG, Kim BS, Yook JH, Kim BS.Totally laparoscopic total gastrectomy using endoscopic linear stapler: early experiences at one institute. J Laparoendosc Adv Surg Tech A. 2012 Nov;22(9):889-97.
97) Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, Kang YK. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer. Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9.
98) Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med. 2012 Oct 3;12:172.
99) Lee IS, Kim TH, Kim YH, Yook JH, Kim BS, Han DJ. Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg. 2012 Aug;36(8):1806-10.
100) Park YS, Hwang HS, Park HJ, Ryu MH, Chang HM, Yook JH, Kim BS, Jang SJ, Kang YK. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Hum Pathol. 2012 Mar;43(3):413-22.
101) Hwang S, Hong HN, Kim HS, Park SR, Won YJ, Choi ST, Choi D, Lee SG. Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int. 2012 Mar 1;36(3):279-88.
102) Kim MY, Park YS, Choi KD, Lee JH, Choi KS, Kim DH, Song HJ, Lee GH, Jung HY, Kim JH, Yun SC, Kim KC, Yook JH, Oh ST, Kim BS, Ryu MH, Kang YK. Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less J Clin Gastroenterol. 2012 Feb;46(2):130-7.
103) Lee JH, Choi KD, Kim MY, Choi KS, Kim DH, Park YS, Kim KC, Song HJ, Lee GH, Jung HY, Yook JH, Kim BS, Kang YK, Kim JH. Clinical impact of EUS-guided Trucut biopsy results on decision making for patients with gastric subepithelial tumors ≥ 2 cm in diameter.
Gastrointest Endosc. 2011 Nov;74(5):1010-8.
104) Kim KC, Koh YW, Chang HM, Kim TH, Yook JH, Kim BS, Jang SJ, Park YS. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Ann Surg Oncol. 2011 Oct;18(10):2833-40.
105) Kim BS, Yook JH, Choi YB, Kim KC, Kim MG, Kim TH, Kawada H, Kim BS. Comparison of early outcomes of intracorporeal and extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A. 2011 Jun;21(5):387-91.
106) Kang YK, Ryu MH, Yoo C, Chang HM, Yook JH, Oh ST, Kim BS, Kim TW. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2011 Jun;67(6):1435-43.
107) Kim MG, Yook JH, Kim KC, Kim TH, Kim HS, Kim BS, Kim BS. Influence of obesity on early surgical outcomes of laparoscopic-assisted gastrectomy in gastric cancer. Surg Laparosc Endosc Percutan Tech. 2011 Jun;21(3):151-4.
108) Kim MG, Kim KC, Kim BS, Kim TH, Kim HS, Yook JH, Kim BS. A totally laparoscopic distal gastrectomy can be an effective way of performing laparoscopic gastrectomy in obese patients (body mass index≥30). World J Surg. 2011 Jun;35(6):1327-32.
109) Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, Lee JH, Kim MY, Kim BS, Oh ST, Yook JH, Jang SJ, Yun SC, Kim SO, Kim JH. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc. 2011 May;73(5):942-8.
110) Chung JW, Jung HY, Choi KD, Song HJ, Lee GH, Jang SJ, Park YS, Yook JH, Oh ST, Kim BS, Kim JH. Extended indication of endoscopic resection for mucosal early gastric cancer: analysis of a single center experience. J Gastroenterol Hepatol. 2011 May;26(5):884-7.
111) Kim MG, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc. 2011 Apr;80(4):245-50.
112) Kim MG, Kawada H, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. A totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG) for improvement of the early surgical outcomes in high BMI patients. Surg Endosc. 2011 Apr;25(4):1076-82.
113) Kim BS, Oh ST, Yook JH, Kim KC, Kim MG, Jeong JW, Kim BS. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am J Surg. 2010 Sep;200(3):328-33.
114) Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Cancer Chemother Pharmacol. 2010 Jul;66(2):373-80.
115) Kim JH, Song HY, Hu HT, Kang YK, Jung HY, Yook JH, Kim BS. Palliative treatment of malignant gastric outlet obstructions with a large-diameter metallic stent: prospective preliminary study. J Vasc Interv Radiol. 2010 Jul;21(7):1125-8.
116) Yoon SN, Roh SA, Cho DH, Kim MB, Hyun YL, Ro S, Kim BS, Kim SY, Kim YS, Kim JC. In vitro chemosensitivity of gastric adenocarcinomas to histone deacetylase inhibitors, compared to established drugs. Hepatogastroenterology. 2010 May-Jun;57(99-100):657-62.
117) Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.
Ann Surg Oncol. 2010 Apr;17(4):1024-32.
118) Sym SJ, Chang HM, Kang HJ, Lee SS, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer. Cancer Chemother Pharmacol. 2008 Dec;63(1):1-8.
119) Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Kim HC, Kim KH, Yook JH, Kim BS, Kang YK. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs). J Surg Oncol. 2008 Jul 1;98(1):27-33.
120) Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 2008 Jul;15(7):1968-76.
121) Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7.
122) Kim JH, Song HY, Park SW, Yoon CJ, Shin JH, Yook JH, Kim BS. Early symptomatic strictures after gastric surgery: palliation with balloon dilation and stent placement. J Vasc Interv Radiol. 2008 Apr;19(4):565-70.
123) Chang HM, Ryu MH, Lee H, Jang SJ, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors. Oncology. 2008;74(1-2):88-95.
124) Song HY, Kim TH, Choi EK, Kim JH, Kim KR, Shin JH, Lee SK, Kim TW, Yook JH, Kim BS. Metallic stent placement in patients with recurrent cancer after gastrojejunostomy. J Vasc Interv Radiol. 2007 Dec;18(12):1538-46.
125) Yang ZQ, Song HY, Kim JH, Shin JH, Kim TW, Yook JH, Kim BS. Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction. J Vasc Interv Radiol. 2007 Dec;18(12):1533-7.
126) Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, Lee GH, Lee SK, Kim MH, Ryu MH, Kang YK, Kim BS, Yook JH. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc. 2007 Aug;66(2):256-64.
127) Kim JH, Song HY, Shin JH, Choi E, Kim TW, Lee SK, Kim BS. Stent collapse as a delayed complication of placement of a covered gastroduodenal stent. AJR Am J Roentgenol. 2007 Jun;188(6):1495-9.
128) Kim KH, Kim HS, Lee YJ, Park KM, Hwang S, Ahn CS, Moon DB, Ha TY, Kim YD, Kim KK, Song KW, Choi ST, Kim DS, Jung DH, Lee SG. Clinical analysis of right anterior segmentectomy for hepatic malignancy. Hepatogastroenterology. 2006 Nov-Dec;53(72):836-9.
129) Oh JS, Lee JL, Kim MJ, Ryu MH, Chang HM, Kim TW, Jang SJ, Yook JH, Oh ST, Kim BS, Kang YK. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases. Cancer Res Treat. 2006;38(3):178-83.
130) Kim HC, Kim JC, Roh SA, Yu CS, Yook JH, Oh ST, Kim BS, Park KC, Chang R. Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol. 2005 Nov;131(11):733-40.
131) Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapy. Cancer Res Treat. 2005 Aug;37(4):201-7.
132) Song HY, Shin JH, Yoon CJ, Lee GH, Kim TW, Lee SK, Yook JH, Kim BS. A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures. J Vasc Interv Radiol. 2004 Dec;15(12):1443-9.
133) Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res. 2004 May 1;10(9):3076-81.